West Pharmaceutical Opens Second Manufacturing Plant in China

Article

West Pharmaceutical Services opens its second manufacturing plant in China to expand presence in Asian markets.

West Pharmaceutical Services, a provider of solutions for injectable-drug administration, started up its compression-molding plant in the Shanghai Zhangjiang High-Tech Industrial Development Zone Qingpu Park in China. The new plant is adjacent to West’s injection-molding facility that was dedicated in September 2009.

The 11,900-m2 compression-molding plant manufactures components used for packaging injectable drugs, supplying customers primarily in China and the Asia-Pacific region. Construction began in June 2011.

In addition to the plants in Qingpu, West’s presence in the Asia-Pacific region includes a factory in Singapore and sales offices in Australia, China, India and Singapore. The company’s first manufacturing facility in India is under construction.

Source: West Pharmaceutical Services

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content